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Highlights: 9 
 Infection of horses with the liver fluke, Fasciola hepatica, is relatively common 10 
 There is little information available on the epidemiology and pathogenesis of fasciolosis in 11 
this host 12 
 Experimental challenge did not establish either infection or seroconversion in this study 13 
 The performance of antibody-detection and coproantigen tests established for diagnosis of 14 
fasciolosis in ruminants is not optimal in horses 15 
 Many questions remain to be answered in understanding the importance of liver fluke 16 





Fasciola hepatica is a common parasite of livestock in Ireland, causing significant economic 20 
losses and affecting animal welfare.  A previous abattoir study of 200 horses led to an estimated 21 
9.5% prevalence of infection in horses slaughtered in Ireland. However, the epidemiology and 22 
pathogenic significance of this infection in this species is not well-described.    23 
The objectives of this study were to determine the susceptibility of horses to oral challenge 24 
infection with F. hepatica metacercariae, and to document the course of the infection along with 25 
serological and biochemical response. 26 
We attempted an experimental infection of horses (n=10; 9 geldings and 1 mare) with F. 27 
hepatica.  Four were given 1000 metacercariae, four 500 metacercariae and two were sham-28 
infected.  Blood and faecal samples were taken at intervals up to 18 weeks post-infection (wpi).  29 
ELISA assays were used to assess sero-conversion in the experimental horses and also in a panel 30 
of sera from horses of known fluke status. 31 
No flukes were recovered from any of the livers, and neither were any lesions that could be 32 
attributed to F. hepatica infection observed. Coproantigen ELISA was negative throughout for all 33 
horses.  Three antibody detection ELISAs, useful in diagnosing fasciolosis in other species, had 34 
limitations as diagnostic aids as determined using a panel of sera from horses of known F. 35 
hepatica infection status.  36 
This study is limited by the relatively small number of animals included, and the relatively short 37 
duration of the study period. 38 
Failure to establish infection after oral challenge raises fundamental questions on the 39 
pathophysiology and epidemiology of equine fasciolosis.    40 




1. Introduction 43 
Infection with Fasciola hepatica or the common liver fluke is widespread in livestock in Ireland, due 44 
to the favourable environmental conditions for the liver fluke and its intermediate host, most 45 
commonly the mud snail Galba truncatula.  In dairy herds, bulk milk ELISA surveys have led to 46 
estimates of liver fluke exposure in 82% (Selemetas et al., 2015).  Other mammalian species 47 
including goats, deer and horses which graze on fluke-infected pastures can also become infected 48 
(Taylor et al., 2007).    49 
F. hepatica is found in equine livers in Europe as documented in anecdotal reports, peer-reviewed 50 
clinical cases and surveys [Howell et. al., 2019; Williams and Hodgkinson, 2017). The prevalence of 51 
liver fluke infection in the horse can be high, for example with 60% seroprevalence reported in Spain 52 
(Arias et al., 2012) but tends to be less than in ruminants (Quigley et al., 2015).  53 
Despite these reports, experimental infections have not been successful, and relatively few  54 
investigations documenting the equine response to experimental infection are found in the 55 
literature (Nansen et al., 1975; Alves et al., 1988;. Soulé et al., 1989).   The reasons for this 56 
dichotomy are not well understood, but could be due to method of infection, strain of parasite, or 57 
factors related to individual hosts.  We therefore undertook an experimental challenge to further 58 
understand the equine response to F. hepatica challenge.   59 
We also used a sub-group of 82 equine sera of known fluke status to compare the sensitivity and 60 
specificity of three antibody-detection ELISAs in the horse;   an in-house  CL1 ELISA (Collins et al., 61 
2004), an ELISA using a recombinant surface protein, Paz-Silva et al., (2012) and an ELISA based on 62 





2. Materials and Methods 66 
2.1 Animals 67 
Ten horses destined for the food chain were procured from a commercial source and maintained on 68 
pasture at UCD Lyons Research Farm.  The horses were of mixed breeds, and between 2 and 20 69 
years of age, as described in Table 1.   Horses were randomly assigned to either infection or control 70 
groups, and none had F. hepatica eggs in faeces.   Prior to the start of the experiment all horses were 71 
treated with 0.4mg /kg moxidectin  and 2.5mg/kg praziquantel  (Equest Pramox, Zoetis ), and 72 
12mg/kg triclabendazole  (Fasinex 10% oral solution, Elanco). 73 
 74 
 75 
2.2 Experimental infection 76 
F. hepatica metacercariae (n=10,000), Italian strain, were obtained from Ridgeway Research, 77 
Gloucester, UK).   Fluke viability was assayed by in vitro excystation followed by observation of 78 
metacercarial mobility. A suspension of 150 metacercariae per ml of distilled water was prepared. 79 
The fluid was swirled to ensure even distribution of the metacercariae prior to loading syringes, and 80 
doses of 500 (horses 1-4, Group A) and 1000 (horses 5-8, Group B) individual viable metacercariae 81 
were administered by syringe. The 20 ml syringe was inserted through the side of the mouth, and 82 
the contents expelled onto the back of the tongue.  The same syringe was then re-loaded with water 83 
and the horses dosed again to ensure any metacercariae remaining in the syringe were 84 
administered.  Two of the 10 horses (Group C) were sham infected using water only. 85 
2.3 Sampling 86 
Blood was taken on day of infection and at four weekly intervals thereafter.  Blood samples were 87 
obtained by jugular venepuncture.  The vein was raised using digital pressure, and 9 ml of blood 88 
collected in a plain vacutainer using a 19-gauge needle.  The jugular region was examined post-89 
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sampling for any signs of haematoma, swelling or bleeding.  The side of the neck used was 90 
alternated at every venepuncture.  After the blood had clotted, vacutainers were centrifuged at 91 
5000 g for 10 min and supernatants aliquoted and stored at -80°C until assay.   Faecal samples were 92 
taken per rectum at 14 and 18 wpi.  93 
2.4 Serological analysis 94 
Sera from the 10 experimental horses were examined for antibodies specific for F. hepatica using an 95 
in-house ELISA based on a recombinant mutant cathepsin L1 antigen (rmFhCL1, Collins et al., 2004) 96 
at day of infection, and at 4, 8, 12, 16, and 18 weeks post-infection (wpi).   Eighty-two serum samples 97 
collected as part of a previous abattoir survey of horses (6) were also examined using this assay, plus 98 
two other antibody detection assays, one based on purified F. hepatica ES antigens (Howell et al., 99 
2019) and the second on  FhrAPS, a 2.9 kDa recombinant protein derived from the fluke tegument 100 
(Paz-Silva et al., 2012). 101 
2.4.1 Recombinant mutant Cathepsin L1 ELISA  102 
ELISA plates were coated with recombinant mutant CL1 (Collins et al., 2004) at a concentration of 1 103 
µg/ml in 50 mmol/l carbonate/bicarbonate coating buffer and incubated for 1 h at 37°C. Columns 104 
were alternately coated with antigen or with buffer only to provide a background control. Plates 105 
were washed 3 times with phosphate-buffered saline with Tween 20 (PBST), and this wash protocol 106 
repeated after each incubation. Plates were blocked with 5% skimmed milk powder in PBST at 100 µl 107 
per well, and incubated for 1 h at 37°C. Sera were diluted 1:100 in 2% skimmed milk powder in PBST, 108 
and 100 µl per well, added (in duplicate), and incubated for 1 h at 37°C. HRPO-conjugated goat anti-109 
horse immunoglobulin IgGT  (Biorad) was diluted 1:20,000 in the same buffer, added at 100 µl per 110 
well, and incubated for 1 h at 37°C. 3,3’,5,5’- Tetramethylbenzidine (TMB) substrate was added, at 111 
100 µl per well,  colour was allowed to develop for 10 min and then stopped with 1 mol/l H2SO4, at 112 
100 µl per well. Plates were read on a Dynamica LEDetect plate reader at 450nm and corrected 113 
optical densities (ODs) were calculated by subtracting the background OD for each serum sample 114 
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incubated on non-antigen coated wells. The cut-off value for the test was determined to be 0.15 at 115 
OD 450 nm.  116 
2.4.2 FhrAPS Indirect ELISA 117 
ELISAs using the F. hepatica FhrAPS, a 2.9 kDa recombinant protein were performed on serum 118 
samples as previously described (Paz-Silva et al., 2005).  The protein concentration used to coat the 119 
wells of the polystyrene plates was 3 µg/ml, sera were diluted (tested in duplicate) at 1:200 in PBS-120 
0.3% Tween 20 and 10% skimmed milk, and horseradish peroxidase conjugated protein G (Nordic 121 
Immunology Laboratories) at 1:1000. Substrate consisting of 10 mg of ortho-phenylenediamine, 12 122 
ml citrate buffer and 10 µl of 30% hydrogen peroxide was then added to each well. The plates were 123 
incubated in the dark for 10 min at room temperature. The enzymatic reaction was stopped with 124 
100 µl per well of 3N sulphuric acid, and absorbances were read using a spectrophotometer (Titertek 125 
Multiskan) at 492 nm. 126 
2.4.3 F. hepatica Excretory-Secretory (ES) ELISA 127 
An ES antibody detection ELISA validated in cattle was used, with minor modifications as described 128 
by Howell et al., 2019.  Briefly, the modified protocol involved the use of 2% BSA as a blocking 129 
buffer,  dilution of equine serum samples to 1:200, and use of a goat anti-horse HRPO conjugate 130 
(Biorad) as secondary antibody. 131 
2.5 Biochemical Analysis 132 
Serum glutamate dehydrogenase([GLDH) and g-glutamyltransferase (GGT) were measured using a 133 
Randox RX Imola analyser. Samples were also tested for bile acid levels using the same analyser 134 
 135 
2.6 Faecal Analysis 136 
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Faecal samples were collected at 14 and 18 wpi and were assayed by sedimentation for F. hepatica 137 
eggs and by F. hepatica coproantigen ELISA (Bio-X Diagnostics). 138 
The horses went to abattoir at 20 wpi.   On the day of collection, livers were examined for signs of 139 
pathology or overt signs of fluke infection.  They were then kept frozen at -20°C until determination 140 
of fluke burden.  Livers were thawed for 24h minimum, and each liver was cut into approximately 8 141 
cm slices and placed into warm water.  Each slice was then cut into approximately 1 cm cubes and 142 
further examined for flukes.  Liver cubes (approximately 15 at a time) were collected in muslin gauze 143 
and thoroughly squeezed to release any parasites, following which the liquid was filtered twice, first 144 
in a sieve and then in a 0.35 micron mesh filter, and any particulate matter retained for examination.   145 
3.0 Results 146 
 147 
3.1  Viability of metacercariae. 148 
The viability of the metacercariae used for this protocol was 70%, in line with other batches 149 
received by our laboratory.  The same batch of metacarcariae were used for experimental 150 
infection of a group of young cattle, in a separate study, three months after the challenge in this 151 
study.  Each animal  in this study was orally dosed with 150 metacercariae, and the establishment 152 
rates were between 42-63 flukes at post-mortem examination.  153 
3.2 Gross morphology of livers and fluke burden 154 
Observations were made on each liver post-mortem.  There were no overt signs of liver fluke 155 
infection. Bile ducts were not calcified or enlarged and no liver flukes or tracts were observed.  156 
Evidence of prior Echinococcus granulosis infection (large hydatid cyst) was present in liver number 157 
seven.   Experimental challenge with F. hepatica failed to establish patent infection. 158 
3.3 Faecal analysis  159 
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  Faecal samples collected at both time points were negative for fluke eggs, and also for the F. 160 
hepatica coproantigen test.   161 
3.4 Serum biochemistry and antibodies 162 
Three of the horses in Group B, which were challenged with 1000 F. hepatica metacercariae, had 163 
serum levels of GGT above the reference range at various timepoints (Figure 1a).   However, in the 164 
case of two of these animals, numbers 5 and 8, elevated values were already present at the day of 165 
infection.  Values in horse 5 returned to the normal range by 8 wpi, but generally remained elevated 166 
in horse 8.  In horse 7, a transient elevation was measured at 8 wpi only.  Horse 5 also had elevated 167 
GLDH levels at the day of infection (Figure 1b).  For all other samples GLDH was within the reference 168 
range.  No elevations in bile acids above the reference range were recorded (Figure 1c).  169 
Of the ten horses assayed from the three experimental groups, four were positive for antibodies 170 
specific to rmFhCL1 (Figure 2).    Two horses had moderately high levels of antibodies, namely, #3 171 
and #7, from Group A and Group B, respectively.  Horses #6 (Group B) and #10 (control, Group C) 172 
both had slightly elevated levels of antibodies. No F. hepatica parasites were found in any of the 173 
livers.   174 
3.5 Comparison of Cathepsin L1, 2.9 kDa recombinant surface protein (FhrAPS) and ES ELISAs for 175 
detection of antibodies against F. hepatica in horses. 176 
When used to compare performance on 82 serum samples from horses of known fluke infection 177 
status collected as part of a previous abattoir survey [6)] the FhrAPS ELISA gave the highest 178 
sensitivity, 72% Sn (95% C.I. 46.5 to 90.3%), but also the lowest specificity, 30% Sp (95% C.I. 18.9 to 179 
42.4%). The ES ELISA showed a sensitivity of 67% (95% C.I. 40%-87%) and a specificity of 97% (95% 180 
C.I. 89%-100%) and the rmFhCL1 ELISA had the lowest sensitivity, 50% Sn (95% C.I. 26%-74%) and 181 
the highest specificity of 100% Sp (95%C.I. 94%-100%), as shown in Table 2.  182 
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Kappa values were determined to measure agreement between the tests, (Table 3).  The rmFhCL1 183 
ELISA and the ES ELISA have a kappa value of 0.57, which indicates moderate agreement.  The kappa 184 
value for the CL1 ELISA and the FhrAPS ELISA is 0.067, which indicates there is slight agreement 185 
(Dohoo et al., 2003). 186 
 4.0 Discussion  187 
Our experimental challenge study supports previous observations on the difficulty in establishing 188 
experimental infection of horses with F. hepatica (Nansen et al., 1975; Alves et al., 1988;. Soulé et 189 
al., 1989), in spite of a prevalence of 9.5 % of infection in horses in a relatively recent abattoir study 190 
in Ireland (Quigley et al., 2017).  Neither did our experimental challenge protocol provide convincing 191 
evidence of seroconversion, or of pathology within the liver in the experimental time frame.  192 
Coproantigen results were negative and ELISA results on the sera were mixed.  In two horses, #3 and 193 
7, high levels of antibodies specific for rmFhCL1 were detected, however as the antibody level was 194 
elevated on the day of infection, we considered that this positive result was more likely due to 195 
previous exposure or to poor specificity, rather than experimental infection.   Negative coproantigen 196 
results in horses have previously been reported (Palmer et al., 2017) and may be due to the 197 
extensive hindgut fermentation in equids. 198 
Previous studies on the experimental infection of horses with Fasciola hepatica led to the conclusion 199 
that horses are largely resistant to liver fluke infection.  Nansen et al., (1975), infected horses both 200 
orally and by intraperitoneal implantation and found that only one of ten horses dosed orally 201 
became infected.  Both of the horses that were implanted with metacercariae developed a patent 202 
infection.  Hence, the authors concluded that given by the oral route, the majority of parasites were 203 
eliminated or immobilised at an early stage of the infection.  Alves et al., (1988) dosed horses with 204 
both F. hepatica and F. gigantica and found that the horses were resistant to infection with oral 205 
doses of metacercariae ranging from n= 500 up to 9,500.  Boulard et al., (1989) conducted an 206 
experimental infection in which a patent infection was seen in only two of eight horses infected.  The 207 
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question remains, therefore, why natural infection with F. hepatica is reasonably common (Howell et 208 
al., 2019; Quigley et al. 2017).   209 
In our hands, experimental challenge of both cattle and sheep with F. hepatica metacercariae, 210 
including with the Italian strain, invariably produces infection, at lower dose rates than those used in 211 
this study (150 metacercariae for sheep and 200-400 for cattle).  Furthermore,  we used the same 212 
batch of metacercariae to infect cattle, in a separate study.   It is unlikely, therefore, that failure to 213 
infect horses with this protocol was due to technical factors. 214 
It is possible that the pre-patent period in horses is considerably longer than in ruminants, and this 215 
may be one reason why this and previous experimental challenges have not demonstrated patent 216 
infection (Alves et al., 1988).  It is possible that horses are only susceptible to infection within a 217 
certain age range, perhaps as foals, and that the prevalence can be explained by long-lived infection.  218 
Alternatively, the possibility of strain-specific infection of horses has been mooted, although this is a 219 
relatively unlikely possibility given the high genetic diversity of F. hepatica populations (Beesley et 220 
al., 2017).  Furthermore, Howell et al. (2019) recently demonstrated no differences in the genetic 221 
diversity of flukes recovered from horses and from ruminants in the UK, and a high level of gene flow 222 
between these populations, showing that at least in this geographical region equine-specific strains 223 
do not occur.  Cross-infection between horses and ruminants is also suggested by the work of this 224 
group by showing an increased risk of F. hepatica infection in horses co-grazing with ruminants.   The 225 
ability of horses to mount an effective protective immune response following a primary infection can 226 
also not be excluded as a possibility, and we acknowledge that the horses in this study may have 227 
been exposed to prior infection.   There may also be individual animal risk factors/susceptibilities 228 
within equine populations, that are as yet undefined.   In any event, it is clear that there are 229 
significant gaps in our knowledge of equine fasciolosis that cannot be extrapolated directly from the 230 
established picture of ruminant infection.   Further understanding of the epidemiology of equine 231 
fasciolosis could be achieved, for example, by studying the age-prevalence, or by prospective natural 232 
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challenge studies on horses co-grazed with infected ruminants.   These studies will be useful not only 233 
in determining optimal control programmes for equine fasciolosis, but also potentially in illuminating 234 
the more basic aspects of host-parasite relationships pertaining to F. hepatica.    235 
Another issue hindering elucidation of the epidemiology of equine fasciolosis is the relative lack of 236 
reliable diagnostic tests.   In our hands, a serum antibody-detection ELISA assay based on a 237 
recombinant form of the major adult fluke ES protein, cathepsin L1, provided a relatively low 238 
sensitivity, although a high specificity.  An assay based on purified ES protein from adult flukes 239 
provided a higher sensitivity and a relatively high specificity.  We expected that the performance of 240 
these two assays would be comparable as FhCL1 is a major component of the ES fraction (Jeffries et 241 
al. 2001). The difference in sensitivity is likely to be due to the presence of additional antigens in the 242 
ES ELISA that are recognised during liver fluke infection of the horse.   Although a third ELISA based 243 
on a 2.9kDa tegumental protein expressed in E. coli identified all horses with confirmed active 244 
infection, it had a low specificity, and hence did not have a high level of concordance with the other 245 
two assays.    The optimisation of serological diagnosis for equine fasciolosis will also be an 246 
important factor in understanding its pathophysiology and epidemiology, while also perhaps 247 
shedding light on the factors underlying susceptibility of different species as definitive hosts.   An 248 
intriguing phenomenon which is deserving of future study also is the apparent failure of some horses 249 
at least to mount a strong antibody response to the FhCL1 antigen, which is immunodominant in 250 
ruminants (Garza-Cuartero et al., 2018) and humans (O’Neill et al., 1999) infected with F. hepatica.   251 
Understanding this aspect of the equine immune response to F. hepatica may be useful in the 252 
broader context of understanding host-parasite relationships in fasciolosis. 253 
5.0  Conclusions 254 
In summary, this and previous studies confirm that while F. hepatica infection is relatively common 255 
in horses, there are many unanswered questions relating to its epidemiology, pathophysiology and 256 
diagnosis.   These gaps, together with the absence of any licensed treatment, limit the advice that 257 
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can be provided in relation to equine fasciolosis.   Co-grazing or rotational grazing of horses with 258 
ruminants on pastures where fluke infection is known to occur should prompt vigilance for potential 259 
related clinical signs in horses.   Improved diagnostics will be required to improve our knowledge of 260 
the epidemiology and clinical importance of F. hepatica infection in the horse. 261 
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Horse no. Group Age (yrs) Breed Sex Dose 
(metacercariae) 
1 A 8 TB Gelding 500 
2 A 14 TB Gelding 500 
3 A 9 ISH Mare 500 
4 A 20 ISH Gelding 500 
5 B 8 ISH Gelding 1000 
6 B 11 ISH Gelding 1000 
7 B 11 ISH Gelding 1000 
8 B 17 TB Gelding 1000 
9 C 12 TB Gelding nil 
10 C 17 TB Gelding nil 
Table 1.  Horses included in the study.   These were horses destined for slaughter, purchased from a 340 
variety of locations throughout Ireland.  They were maintained on fluke-free grazing for the duration 341 
of the study.  TB= Thoroughbred, ISH= Irish Sport Horse.  Four horses were challenged orally with 342 
500 F. hepatica metacercariae (Italian strain), four with 1000 metacercariae, and two were given a 343 
sham challenge. 344 
 345 





































91 (85- 95) 90 (82-96) 
FhrAPS 72(47-9) 30(19-42) 22(14-33) 23 (18-
29) 
78 (61-89) 39(28-50) 
       
Table 2.   Performance of ELISAs. Sensitivity, specificity, indicative sero-prevalence, positive and 346 
negative predictive values, and accuracy determined for each of the three antibody-detection ELISA 347 
assays using a sub-group of 82 equine sera collected from horses in a previous abbatoir survey.   348 
Each sample was from a horse of known status with respect to current liver fluke infection, and of 349 
this population,  22% had evidence of infection.  All values are given as percentages with the upper 350 
and lower limit of the 95% confidence interval in brackets.    351 
  352 
 CL1 ES ELISA Fhr APS 
CL1 n/a 0.57 0.067 
ES ELISA  n/a 0.179 
FhrAPS   n/a 
Table 3   Agreement between assays. Kappa values, indicating moderate agreement between the 353 




Figure Legends 356 
Figure 1. Serum GLDH (a) GGT (b) and bile acid (c) levels for each horse from day of infection through 357 
18 weeks post-infection.  The horizontal line indicates the upper level of the reference range, in each 358 
case.   Horses 1-4 (Group A) were challenged with 500 metacercariae, 5-8 (Group B) with 1000, and 9 359 
and 10 (Group C) were unchallenged.  Serum bile acids did not rise above the reference range in any 360 
animal.  Two horses from Group B, numbers 5 and 8, had elevated serum GLDH on the day of 361 
infection, but these levels subsequently declined.  These two horses also had serum GGT levels 362 
above the reference range at this timepoint, and in the case of horse 8 elevated levels persisted 363 
throughout the study period.  Horse 7 had transiently elevated GGT at 4 wpi. 364 
Figure 2.  ELISA results as corrected O.D. 450 nm values of horse sera were determined by rmFhCLq 365 
ELISA.  Results from individual horses numbered 1-10 are displayed on X-axis.  Horses 1-4 were 366 
dosed with 500 metacercariae (Group A) 5-8 were dosed with 1000 metacercariae (Group B) and 9 367 
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